Delayed Prostate Cancer Therapy Lancaster NY

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Local Companies

Stephen Edge
(716) 845-2300
Elm And Carlton St
Buffalo, NY
Donald Lynn Trump, MD
716-845-3499
Elm and Carlton St
Buffalo, NY
William Gress Kraybill, MD
716-845-3284
Elm and Carlton St
Buffalo, NY
Maria R Baer, MD
716-845-5975
Elm and Carlton St
Buffalo, NY
Bagirathan Janartha, MD
716-845-7614
Elm and Carlton St
Buffalo, NY
Daniel Green
(716) 845-2300
Elm And Carlton St
Buffalo, NY
MARY PETRUZZI, MD
(716) 878-7349
219 Bryant Street
Buffalo, NY
Moneer Abd-El W Khalil, MD
716-565-9999
45 Spindrift Dr
Williamsville, NY
Amy Papalia Early, MD
716-630-1029
295 Essjay Rd
Williamsville, NY
J Alexander Palesty, MD
716-845-5738
Carlton and Elm Streets,
Buffalo, NY
Data Provided by:
    

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Exercise for Prostate Cancer Lancaster NY
Regular exercise may help protect men from prostate cancer, says a new study. U.S. researchers looked at 190 men who had a prostate biopsy and found that those who were moderately active -- anything equivalent to walking at a moderate pace for several hours a week -- were significantly less likely to be diagnosed with prostate cancer.
- Hormone Therapy for Breast Cancer Lancaster NY
- Open Prostatectomy Versus Laparoscopic Procedure Lancaster NY
- Hormone Therapy for Early Prostate Cancer Lancaster NY
- Drug Combo Proves Powerful Against Lung Cancer Lancaster NY
- Hormone Therapy for Lung Cancer Lancaster NY
- Hormone Therapy for Prostate Cancer Lancaster NY
- Attack Of The Cancer Fighting Tomatoes Lancaster NY
- Diagnosis of Prostate Cancer Lancaster NY
- Head and Neck Cancer Treatment Lancaster NY